Version 6.0 September 11, 2017 RESOLVE Protocol Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects with previous DAA experience Sponsored by Institute of Human Virology, University of Maryland School of Medicine Baltimore, MD And Gilead Sciences, Inc. Foster City, California IND Number 128754 IND sponsored by Institute of Human Virology, University of Maryland School of Medicine Baltimore, MD Medical Monitor Theo Heller, MD Principal Investigator: Eleanor Wilson, MD, MHS Assistant Professor of Medicine Institute of Human Virology University of Maryland School of Medicine 725 W Lombard Street, Room S218 Baltimore MD 21201 Phone: (410) 706-1710 IRB Initial Approval: February 22, 2016 RESOLVE PROTOCOL PROTOCOL DATE: SEPTEMBER 11, 2017 STUDY ROSTER AND CONTACT INFORMATION Principal Investigator: Protocol Statistician: Eleanor Wilson, MD, MHS Søren Bentzen, Ph.D., Assistant Professor of Medicine Biostatistics Research Branch Institute of Human Virology University of Maryland University of Maryland School of Medicine 725 W Lombard Street, Room S218 Baltimore MD 21201 Collaborating Investigators: Phone: (410) 706-1710 Gebeyehu Teferi, MD, Unity Health Care
[email protected] Collaborating Institutions: Research contact/Study Coordinator: Jennifer Hoffmann, MSN, MPH Unity Health Care, Inc./Walker Jones Site AI: Gebeyehu Teferi, MD Associate Investigators: FWA: 00009653, expiration date 6/19/2018 Elizabeth Akoth, RN 40 Patterson Street, NE Benjamin Emmanuel, MPH Washington, DC 20002 Emily Comstock,